Demography
| Subject | Sex | Age (y) | Clinical diagnosis | MMSE | Dose (MBq) | Arterial sampling | Amyloid PET |
| HE | |||||||
| 1 | F | 59 | HE | 29 | 161 | Yes | NA |
| 2 | M | 66 | HE | 29 | 153 | Yes | NA |
| 3 | M | 68 | HE | 29 | 155 | Yes | NA |
| 4 | M | 72 | HE | 29 | 152 | No | Negative |
| AD/MCI | |||||||
| 5 | M | 75 | AD | 21 | 169 | No | NA |
| 6 | M | 67 | AD | 11 | 160 | Yes | NA |
| 7 | M | 74 | MCI | 28 | 162 | Yes | Positive |
| 8 | M | 74 | AD | 13 | 163 | No | NA |
| 9 | F | 70 | AD | 13 | 157 | Mo | NA |
| 10 | M | 80 | MCI | 27 | 158 | Yes | Positive |
Amyloid PET = 18F-florbetaben or 18F-flutemetamol amyloid PET scan supporting AD diagnosis; NA = not available.
Additional diagnostic details about cerebrospinal fluid, PET, and MRI results are provided in Supplemental Table 1.